IMMAGE SYSTEM DIGOXIN (DIG) REAGENT/BECKMAN DRUG CALIBRATOR 2

K963062 · Beckman Instruments, Inc. · KXT · Dec 13, 1996 · Clinical Toxicology

Device Facts

Record IDK963062
Device NameIMMAGE SYSTEM DIGOXIN (DIG) REAGENT/BECKMAN DRUG CALIBRATOR 2
ApplicantBeckman Instruments, Inc.
Product CodeKXT · Clinical Toxicology
Decision DateDec 13, 1996
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 862.3320
Device ClassClass 2

Intended Use

The IMMAGE Immunochemistry System Digoxin (DIG) Reagent, in conjunction with Beckman Drug Calibrator 2, is intended for use in the quantitative determination of digoxin in human serum and plasma samples by turbidimetric immunoassay. This assay is designed for use with the IMMAGE Immunochemistry System.

Device Story

IMMAGE Immunochemistry System Digoxin (DIG) Reagent performs quantitative determination of digoxin in human serum and plasma. Device utilizes turbidimetric inhibition immunoassay technology; operates at 37°C. System requires no sample pretreatment. Used in clinical laboratory settings by trained personnel. Output is a quantitative concentration value (ng/mL) used by clinicians to monitor digoxin levels. Benefits include automated, efficient measurement compared to predicate fluorescence polarization methods.

Clinical Evidence

Bench testing only. Performance demonstrated via method comparison against Abbott TDx Digoxin II Reagent using Deming regression (slope 1.011 ± 0.037, intercept 0.047 ± 0.0016, r=0.978). Within-run imprecision evaluated across three levels (0.87, 2.63, 4.19 ng/mL) with CVs ranging from 2.3% to 5.1%. Stability studies confirm 18-month shelf-life and 14-day on-board stability for reagent.

Technological Characteristics

Turbidimetric inhibition immunoassay; operates at 37°C. Analytical range 0.2 to 5 ng/mL. Designed for use on the IMMAGE Immunochemistry System. Reagent shelf-life 18 months; 14-day on-board stability.

Indications for Use

Indicated for the quantitative determination of digoxin concentrations in human serum and plasma samples to assist in clinical monitoring of digoxin levels.

Regulatory Classification

Identification

A digoxin test system is a device intended to measure digoxin, a cardiovascular drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of digoxin overdose and in monitoring levels of digoxin to ensure appropriate therapy.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0} FROM : BECKMAN INSTRUMENTS 714 961 4457 1996, 12-04 16:01 #757 P.02/05 200 South Kraemer Boulevard, Box 8000, Brea, CA 92822-8000 • (714) 993-8321 # BECKMAN Summary of Safety & Effectiveness IMMAGE™ Immunochemistry System Digoxin (DIG) Reagent ## 1.0 Submitted By: K963062 Sheri Hall Manager, Premarket Regulatory Margie George Project Manager, Systems Development Beckman Instruments, Inc. 200 S. Kraemer Blvd., W-337 Brea, California 92822-8000 Telephone: (714) 961-3765 FAX: (714) 961-3759 DEC 13 1996 ## 2.0 Data Submitted: 04 December 1996 ## 3.0 Device Name(s): ### 3.1 Proprietary Names IMMAGE™ Immunochemistry System Digoxin Reagent Beckman Drug Calibrator 2 ### 3.2 Classification Names Digoxin immunological test system (21 CFR 866.5775) Clinical toxicology calibrator (21 CFR 862.3200) ## 4.0 Predicate Device(s): Behring Diagnostics N Latex RF, K942328 Abbott TDx Digoxin II Reagent, K882233 ## 5.0 Description: The IMMAGE System Digoxin (DIG) Reagent is designed for optimal performance on the IMMAGE Immunochemistry System. It is intended for use in the quantitative determination of digoxin concentrations in human serum and plasma samples. ## 6.0 Intended Use: The IMMAGE Immunochemistry System Digoxin (DIG) Reagent, in conjunction with Beckman Drug Calibrator 2, is intended for use in the quantitative determination of digoxin in human serum and plasma samples by turbidimetric immunoassay. This assay is designed for use with the IMMAGE Immunochemistry System. file: ir510k_2.eaa Beckman Instruments, Inc., Section 510(k) Notification IMMAGE™ Immunochemistry System Digoxin (DIG) Reagent Beckman Instruments, Inc. bnc 910-502-1360 • telex: 06-78413 {1} FROM :BECKMAN INSTRUMENTS 714 961 4457 1996,12-04 16:02 #767 P.03/05 ## 7.0 Comparison to Predicate(s): The following table shows similarities and differences between the predicates identified in Section 4.0 of this summary. | Reagent | Reagents/Compounds | Comments | | --- | --- | --- | | DIG Reagent | Intended use for the measurement of digoxin at 37°C | Same as TDx Digoxin II Reagent | | | Reagent measures digoxin in both human plasma and serum samples | Same as TDx Digoxin II Reagent | | | Analytic Range of 0.2 to 5 ng/mL | Same as TDx Digoxin II Reagent | | DIFFERENCES | | | | DIG Reagent | Assay Type | IMMAGE System DIG Reagent uses turbidimetric inhibition immunoassay technology while the predicate uses fluorescence polarization immunoassay technology | | | Sample Pretreatment | IMMAGE System DIG Reagent does not require sample pretreatment while the predicate requires sample pretreatment | ## 8.0 Summary of Performance Data: The data in the Premarket Notification on safety and effectiveness supports a finding of substantial equivalence to chemistry test systems already in commercial distribution. Equivalence is demonstrated through method comparison, stability, and imprecision experiments that relate results obtained from the Abbott Digoxin II Reagent to the IMMAGE DIG Reagent. ### Method Comparison Study Results* IMMAGE DIG Reagent vs. Abbott Digoxin II Reagent | Analyte | Sample | Method | Pre-Test | Predicate | | --- | --- | --- | --- | --- | | IMMAGE DIG | 1.011 ± 0.037 | 0.047 ± 0.0016 | 0.978 | Abbott TDx Digoxin II | *Deming regression analysis ### Stability Study Results | Reagent | Reagent Product Claim | | --- | --- | | IMMAGE DIG | 18 months shelf-life 14-day on board | | Drug Calibrator 2 | 24 months shelf-life 14-day calibration | file: ir610k_2.ssa Beckman Instruments, Inc., Section 510(k) Notification IMMAGE™ Immunochemistry System Digoxin (DIG) Reagent {2} FROM : BECKMAN INSTRUMENTS 714 961 4457 1996, 12-04 16:02 #767 P.04/05 # Estimated Within-Run Imprecision | Material | MEAS (R/mL) | SD (R/mL) | VCV | Number of Results | | --- | --- | --- | --- | --- | | Level 1 | 0.87 | 0.042 | 4.8 | 15 | | Level 1 | 1.32 | 0.088 | 5.1 | 80 | | Level 2 | 2.63 | 0.079 | 3.0 | 80 | | Level 3 | 4.19 | 0.095 | 2.3 | 80 | This summary of safety and effectiveness is being submitted in accordance with the requirements of the Safe Medical Device Act of 1990 and the implementing regulation 21 CFR 807.92. file: ir610k_2.exe Beckman Instruments, Inc., Section 610(k) Notification IMMAGE™ Immunochorimetry System Digoxin (DIG) Reagent
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...